Result of AGM | 25-Apr-2024 | 14:09 | RNS |
Q1 Trading Statement | 25-Apr-2024 | 07:00 | RNS |
Total Voting Rights | 02-Apr-2024 | 13:49 | RNS |
Director/PDMR Shareholding | 28-Mar-2024 | 12:53 | RNS |
Director/PDMR Shareholding | 25-Mar-2024 | 16:47 | RNS |
Annual Report 2023 and Notice of AGM 2024 | 25-Mar-2024 | 14:07 | RNS |
Director/PDMR Shareholding | 12-Mar-2024 | 13:38 | RNS |
Full Year Results | 12-Mar-2024 | 07:00 | RNS |
Dechra Pharmaceuticals | 11-Jan-2024 | 18:00 | RNS |
Trading Statement | 10-Jan-2024 | 07:00 | RNS |
Block listing Interim Review | 01-Dec-2023 | 16:48 | RNS |
Total Voting Rights | 01-Dec-2023 | 16:45 | RNS |
Holding(s) in Company | 17-Nov-2023 | 10:25 | RNS |
Appointment of Chief Financial Officer | 08-Nov-2023 | 07:00 | RNS |
Q3 Trading Statement | 07-Nov-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 1,326.00p |
Change Today | 8.00p |
% Change | 0.61 % |
52 Week High | 1,485.00p |
52 Week Low | 960.40p |
Volume | 1,587,595 |
Shares Issued | 319.69m |
Market Cap | £4,239.06m |
RiskGrade | 168 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 10 |
Sell | 1 |
Strong Sell | 0 |
Total | 15 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 20-Jun-24 | 12-Oct-23 |
Paid | 12-Jul-24 | 03-Nov-23 |
Amount | 40.00p | 20.00p |
Time | Volume / Share Price |
10:43 | 25 @ 1,312.00p |
15:42 | 5 @ 1,324.00p |
15:36 | 19 @ 1,323.50p |
15:36 | 48 @ 1,323.50p |
15:24 | 1 @ 1,322.00p |
You are here: research